BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 2425673)

  • 1. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.
    Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G
    J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.
    Johnson DA; Carter-Hamm B; Dralle WM
    Am Rev Respir Dis; 1982 Dec; 126(6):1070-3. PubMed ID: 6817677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
    Sathe S; Sakata M; Beaton AR; Sack RA
    Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.
    Suter S; Chevallier I
    Eur Respir J; 1991 Jan; 4(1):40-9. PubMed ID: 2026237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
    Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
    J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes.
    Velvart M; Fehr K
    Rheumatol Int; 1987; 7(5):195-202. PubMed ID: 3423618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human polymorphonuclear neutrophil elastase, polymorphonuclear neutrophil cathepsin-G, and alpha 2-macroglobulin levels in healthy and inflamed dental pulps.
    Rauschenberger CR; McClanahan SB; Pederson ED; Turner DW; Kaminski EJ
    J Endod; 1994 Nov; 20(11):546-50. PubMed ID: 7543925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa.
    Suter S; Schaad UB; Tegner H; Ohlsson K; Desgrandchamps D; Waldvogel FA
    J Infect Dis; 1986 May; 153(5):902-9. PubMed ID: 3486235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
    Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
    Hansen G; Schuster A; Zubrod C; Wahn V
    Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.
    Berger M; Sorensen RU; Tosi MF; Dearborn DG; Döring G
    J Clin Invest; 1989 Oct; 84(4):1302-13. PubMed ID: 2507578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
    Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
    Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
    Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
    Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
    Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
    Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P; Chignard M
    J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
    Steinmeyer J; Kalbhen DA
    Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis.
    Schaefer RM; Herfs N; Ormanns W; Hörl WH; Heidland A
    Clin Nephrol; 1988 Jun; 29(6):307-11. PubMed ID: 3396234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
    Meyer KC; Zimmerman J
    J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.